Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

419
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
419
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

417
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
417
Analgesia and Pain Management01:25

Analgesia and Pain Management

954
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
954
Psychotherapy01:28

Psychotherapy

233
Psychotherapy is a versatile, nonmedical approach aimed at helping individuals address emotional, behavioral, and interpersonal issues to enhance their overall well-being. It can involve one-on-one sessions, couples counseling, or small group discussions with a therapist. The therapeutic process includes various techniques such as open discussion, interpretation of thoughts and behaviors, active listening, positive reinforcement, and role modeling. Psychotherapy aims to support individuals in...
233
Drug Therapy01:28

Drug Therapy

119
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
119
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

242
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
242

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathology.

Cancer letters·2026
Same author

The endocannabinoid 2-arachidonoylglycerol mediates seasonal life-history transitions in a wild reptile.

The Journal of experimental biology·2026
Same author

Cannabis use patterns and perception of acute pain during brief abstinence: sex-dependent associations with circulating cannabinoid levels.

Psychopharmacology·2026
Same author

Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru<sup>®</sup>, vs an Oil-Based Formulation, Epidyolex<sup>®</sup>, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I Study.

CNS drugs·2026
Same author

Pharmacokinetic and pharmacodynamic properties of cannabigerol in male mice.

The Journal of pharmacology and experimental therapeutics·2026
Same author

A Schedule Shift, Not a Federal Green Light: What Cannabis Rescheduling to Schedule III Would Mean-and What It Would Not.

Cannabis and cannabinoid research·2026

Related Experiment Video

Updated: Oct 20, 2025

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.4K

Endocannabinoid-Based Therapies.

Daniele Piomelli1,2, Alex Mabou Tagne1

  • 1Department of Anatomy and Neurobiology, University of California, Irvine, California 92697, USA;

Annual Review of Pharmacology and Toxicology
|September 13, 2021
PubMed
Summary
This summary is machine-generated.

The endocannabinoid system, regulating physiology, offers therapeutic potential. Targeting its ligands, enzymes, and receptors with novel drugs may treat various diseases.

Keywords:
DGLFAAHMGLNAPE-PLDTHCendocannabinoid

More Related Videos

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

349
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.7K

Related Experiment Videos

Last Updated: Oct 20, 2025

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.4K
Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

349
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.7K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Endocannabinoids are lipid messengers crucial for mammalian physiology.
  • Dysregulation of the endocannabinoid system is linked to various diseases.
  • The system comprises ligands (anandamide, 2-AG), enzymes, transporters, and receptors.

Purpose of the Study:

  • To provide an overview of endocannabinoid formation, deactivation, and biotransformation.
  • To outline the therapeutic potential of pharmacological agents targeting the endocannabinoid system.
  • To discuss agents interfering with endocannabinoid pathways and related signaling.

Main Methods:

  • Review of literature on endocannabinoid system components and functions.
  • Description of small-molecule inhibitors for enzymes and transporters.
  • Discussion of pharmacological agents targeting endocannabinoid metabolism and signaling.

Main Results:

  • Endocannabinoid system modulation presents therapeutic opportunities.
  • Pharmacological agents targeting enzymes, transporters, and receptors are under investigation.
  • Combined targeting of endocannabinoid and related pathways shows promise.

Conclusions:

  • The endocannabinoid system is a significant target for drug development.
  • Pharmacological interventions can modulate endocannabinoid signaling for therapeutic benefit.
  • Future research may focus on multi-target agents for complex diseases.